What happened, in summary

A 44-year-old woman underwent suboptimal debulking surgery for Stage III high-grade serous ovarian cancer. A BRCA2 mutation was later identified. She received 8 cycles of carboplatin, paclitaxel, and cyclophosphamide through a research protocol.

Within months, rising CA-125 and peritoneal recurrence led to radical peritonectomy followed by heated intraperitoneal chemotherapy with paclitaxel and mitomycin C. Fifteen involved para-aortic lymph nodes were removed. She began monthly pegylated liposomal doxorubicin in 2002, and carboplatin was added for 4 cycles in 2004 when imaging showed a new para-aortic node. Long-term maintenance therapy then continued until late 2009.

She subsequently developed several separate squamous cell cancers in the oral cavity. Those tumors required extensive treatment and progressed despite surgery and additional therapy. In 2011, she died from acute airway obstruction during progression of the oral cancer. Her death was documented in the setting of this second malignancy rather than as a direct ovarian cancer event.